Metabolic

Survodutide

Dual GLP-1/glucagon receptor agonist reference material for metabolic signalling studies.

Also indexed as: bi 456906

Indexed literature

Original citations from PubMed and ClinicalTrials.gov matched to Survodutide. Indexing is not a quality endorsement; registration is not a published result.

PubMedReview
Antidiabetic medications in the pipeline.
Hormones (Athens, Greece) · 2026 Oct 19
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
PubMedResearch publication
Interpreting Survodutide Renoprotection in a Hyperfiltration Model.
Diabetes, obesity & metabolism · 2026 Oct 19
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
ClinicalTrials.govRegistered trial — no results posted
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Updated 2026-10-16 · NOT YET RECRUITING PHASE3
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
ClinicalTrials.govRegistered trial — no results posted
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Updated 2026-10-14 · RECRUITING PHASE3
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
ClinicalTrials.govRegistered trial — no results posted
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Updated 2026-10-14 · RECRUITING PHASE3
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
ClinicalTrials.govRegistered trial — no results posted
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Updated 2026-10-14 · RECRUITING PHASE3
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
ClinicalTrials.govRegistered trial — no results posted
SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight
Updated 2026-10-14 · NOT YET RECRUITING PHASE3
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
PubMedResearch publication
Does Survodutide Provide Renoprotection Beyond Its Metabolic and Haemodynamic Effects in Diabetic Kidney Disease?
Diabetes, obesity & metabolism · 2026 Oct 12
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
PubMedResearch publication
Development and validation of a multiplexed LC-HRMS method for nine GLP-1 receptor agonists and its pharmaceutical application.
Journal of chromatography. A · 2026 Oct 11
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
PubMedReview
The Power of Two: Harnessing Dual Glucagon and Incretin Signaling for Treatment of Obesity and Metabolic Dysfunction-Associated Steatohepatitis-A Narrative Review with a Translational Focus.
Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026 Oct 11
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
PubMedResearch publication
Survodutide for the treatment of obesity: Mechanistic rationale, clinical evidence, and remaining uncertainties.
Contemporary clinical trials · 2026 Oct 2
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
ClinicalTrials.govRegistered trial — no results posted
SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
Updated 2026-10-02 · NOT YET RECRUITING PHASE3
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
PubMedResearch publication
Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN).
Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026 Oct
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
PubMedResearch publication
Author Correction: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial.
Nature medicine · 2026 Oct
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
PubMedReview
Gastrointestinal adverse effects of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists: A narrative expert review of approved therapies, oral formulations, and pipeline agents.
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026 Oct
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
PubMedResearch publication
Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes.
The New England journal of medicine · 2026 Oct 1
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
PubMedResearch publication
Nephroprotective Effects of the Dual GCGR/GLP-1R Agonist Survodutide in Hypertension-Accelerated Diabetic Kidney Disease.
Diabetes, obesity & metabolism · 2026 Oct 1
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
ClinicalTrials.govRegistered trial — no results posted
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
Updated 2026-09-30 · COMPLETED PHASE3
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
PubMedResearch publication
Efficacy and Safety of Dual GLP-1/Glucagon Receptor Agonism in Overweight and Obesity: A Class-Specific Systematic Review and Meta-Analysis.
Diabetes, obesity & metabolism · 2026 Sep 29
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
ClinicalTrials.govRegistered trial — no results posted
A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
Updated 2026-09-09 · ACTIVE NOT RECRUITING PHASE1
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
ClinicalTrials.govRegistered trial — no results posted
A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
Updated 2026-09-09 · ACTIVE NOT RECRUITING PHASE1
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
ClinicalTrials.govRegistered trial — no results posted
A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity
Updated 2026-09-09 · RECRUITING PHASE1
A trial registration is not a published result or proof of safety or effectiveness. Registry information is submitted by study sponsors and investigators.
PubMedReview
Recent Studies on the Effectiveness and Safety of Anti-Obesity Medications: A Scoping Review.
Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.
PubMedReview
A review of survodutide: a new dual acting agonist.
Minerva endocrinology · 2026 Sep
PubMed indexing does not establish study quality or product safety. Read the original publication for methods and limitations.

Materials supplied by Basic Tides are for in-vitro laboratory research only. This page contains no protocols, no dosing information and no therapeutic framing; third-party literature is indexed for reference and is not authored, endorsed or interpreted by Basic Tides.